Skip to content

H.R. 796 · 119th Congress (2025–2027)

Second Chance for Moms Act

This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)

Show official title

To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 796’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Mary E. Miller (R-IL-15)
Cosponsors
13 cosponsors

9 original · 4 later

13 R

  1. Rep. Brian Babin (R-TX-36)· Original · Jan 28, 2025
  2. Rep. Andrew S. Clyde (R-GA-9)· Original · Jan 28, 2025
  3. Rep. Andy Harris (R-MD-1)· Original · Jan 28, 2025
  4. Rep. Barry Moore (R-AL-1)· Original · Jan 28, 2025
  5. Rep. Riley M. Moore (R-WV-2)· Original · Jan 28, 2025
  6. Rep. Andrew Ogles (R-TN-5)· Original · Jan 28, 2025
  7. Rep. Claudia Tenney (R-NY-24)· Original · Jan 28, 2025
  8. Rep. Daniel Webster (R-FL-11)· Original · Jan 28, 2025
  9. Rep. Randy K. Weber, Sr. (R-TX-14)· Original · Jan 28, 2025
  10. Rep. Mark Harris (R-NC-8)· Later · Feb 4, 2025
  11. Rep. Gary J. Palmer (R-AL-6)· Later · Feb 6, 2025
  12. Rep. John W. Rose (R-TN-6)· Later · Feb 26, 2025
  13. Rep. Sheri Biggs (R-SC-3)· Later · Apr 1, 2025
Policy area
Health
Subjects
  • Abortion
  • Consumer affairs
  • Prescription drugs
  • Sex and reproductive health
  • Telephone and wireless communication
  • Women's health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Jan 28, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Second Chance for Moms Act

    Display title, Short title · Introduced in House

  2. To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.

    Official title · Introduced in House